| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |